metoclopramide has been researched along with Pituitary Neoplasms in 73 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The response profile of total and monomeric prolactin following the administration of metoclopramide was similar in women with monomeric hyperprolactinemia and normoprolactinemia but different in women with macroprolactinemia." | 7.85 | Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia. ( Calaf, J; Espinós, JJ; Gich, I; Urgell, E; Vanrell, C, 2017) |
| "The ergoline derivative, Metergoline, in a dosage of 4 to 24 mg/day, was administered for one to eight months to 42 patients with hyperprolactinemic amenorrhea." | 7.67 | Treatment of hyperprolactinemic amenorrhea with Metergoline. ( Bohnet, HG; Kato, K; Wolf, AS, 1986) |
| " We have compared the TSH and PRL responses to metoclopramide (MCP) in normal and postpartum lactating women with those in 28 patients with hyperprolactinemia of different origin." | 7.67 | Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients. ( Anile, C; Barbarino, A; De Marinis, L; Maira, G; Mancini, A; Masala, R; Minnielli, S, 1985) |
| "Plasma mineralocorticoid and prolactin levels were evaluated before and 15, 30, 60 and 120 min after the administration of 10 mg metoclopramide in seven normotensive volunteers (42 +/- 5 (SD) years), as well as in ten patients with primary aldosteronism five with aldosterone-producing adenoma (49 +/- 4), and five with bilateral hyperplasia (47 +/- 3)." | 7.66 | Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism. ( von Werder, K; Weber, PC; Witzgall, H, 1983) |
| "The degree of autonomy in prolactin secreting pituitary adenomas and also prolactin secretory reserve in cases with suspected functional galactorrhea syndrome was evaluated with the use of metoclopramide, TRH and L-DOPA." | 7.66 | The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome. ( Jeske, W, 1979) |
| "A patient with a rare combination of prolactinoma and aldosterone producing adrenal adenoma (APA) was reported in relation to studies concerning dopaminergic regulation of PRL and aldosterone secretion." | 5.28 | A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion. ( Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M, 1992) |
| "The patients with microprolactinomas had a low prolactin response (increments less than 300-400%) and delayed TSH response." | 5.28 | [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women]. ( Balabolkin, MI; Gerasimov, GA; Liubimov, AV, 1990) |
| "Pretreatment with metoclopramide enhanced the CRH-induced cortisol increase from 30-120 min after CRH in normal men, but only at 15 and 30 min in 5 agromegalic patients." | 5.27 | Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion. ( Adachi, N; Endoh, M; Horino, M; Ishii, R; Kikuoka, M; Matsuki, M; Nishida, S; Otsuka, R; Oyama, H; Yoneda, M, 1987) |
| "The effect of YRTJ Granule on metoclopramide-induced hyperprolactinemia was tested in rats." | 3.85 | Paeoniflorin and liquiritin, two major constituents in Chinese herbal formulas used to treat hyperprolactinemia-associated disorders, inhibits prolactin secretion in prolactinoma cells by different mechanisms. ( Batey, R; La, L; Li, Y; Wang, C; Wang, L; Wei, Y, 2017) |
| "The response profile of total and monomeric prolactin following the administration of metoclopramide was similar in women with monomeric hyperprolactinemia and normoprolactinemia but different in women with macroprolactinemia." | 3.85 | Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia. ( Calaf, J; Espinós, JJ; Gich, I; Urgell, E; Vanrell, C, 2017) |
| "In 24 patients who had a PRL-secreting pituitary adenoma, diagnosed by pituitary dynamic function tests and CT scan, and confirmed at surgery, the TSH response to a dopamine (DA)-antagonist drug, metoclopramide (MCP), was studied pre- and postoperatively to elucidate whether altered DA tone was present and related to hyperprolactinemia." | 3.67 | Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide. ( Anile, C; Barbarino, A; De Marinis, L; Maira, G; Mancini, A; Menini, E, 1984) |
| " Furthermore, to evaluate whether high circulating PRL levels influence the activity of the opioid system after the menopause, a group of seven postmenopausal subjects was tested before and 1 week after the administration of metoclopramide (10 mg, three times a day), a dopamine receptor antagonist." | 3.67 | Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states. ( Brambilla, F; De Leo, V; Facchinetti, F; Genazzani, AR; Montemagno, U; Nappi, C; Petraglia, F, 1987) |
| " The pharyngeal hypophysis from a patient with primary hypothyroidism was hypertrophic, with TSH cell hyperplasia; while that from a patient treated with metoclopramide, a dopamine-receptor-blocking drug, showed PRL cell hyperplasia." | 3.67 | Immunocytochemical evidence for the ability of the human pharyngeal hypophysis to respond to change in endocrine feedback. ( Ciocca, DR; Puy, LA; Stati, AO, 1985) |
| "The ergoline derivative, Metergoline, in a dosage of 4 to 24 mg/day, was administered for one to eight months to 42 patients with hyperprolactinemic amenorrhea." | 3.67 | Treatment of hyperprolactinemic amenorrhea with Metergoline. ( Bohnet, HG; Kato, K; Wolf, AS, 1986) |
| "In order to determine whether endogenous dopaminergic tone has any role in the diurnal variation in TSH secretion, the 24-h secretory pattern of TSH and the TSH response to a dopamine antagonist, metoclopramide (MCP), were evaluated in normal women (n = 4) and in hyperprolactinemic-amenorrheic women with pituitary microadenoma (n = 6)." | 3.67 | Twenty-four hour secretory pattern of thyroid-stimulating hormone in hyperprolactinemic women with pituitary microadenoma. ( Kato, K; Seki, K; Shima, K; Uesato, T, 1985) |
| " We have compared the TSH and PRL responses to metoclopramide (MCP) in normal and postpartum lactating women with those in 28 patients with hyperprolactinemia of different origin." | 3.67 | Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients. ( Anile, C; Barbarino, A; De Marinis, L; Maira, G; Mancini, A; Masala, R; Minnielli, S, 1985) |
| "The sexual behavior, hypothalamic-pituitary-testicular axis and seminal fluid parameters in three different models of hyperprolactinaemia were studied: patients with prolactin secreting pituitary adenomas, normal volunteers before and during metoclopramide, and psychotic patients on chronic neuroleptic therapy." | 3.66 | Reproductive parameters in prolactinaemic men. ( D'Urso, R; Falaschi, P; Frajese, G; Pompei, P; Rocco, A, 1983) |
| "Plasma mineralocorticoid and prolactin levels were evaluated before and 15, 30, 60 and 120 min after the administration of 10 mg metoclopramide in seven normotensive volunteers (42 +/- 5 (SD) years), as well as in ten patients with primary aldosteronism five with aldosterone-producing adenoma (49 +/- 4), and five with bilateral hyperplasia (47 +/- 3)." | 3.66 | Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism. ( von Werder, K; Weber, PC; Witzgall, H, 1983) |
| " The diagnosis of prolactinoma was made in three of the 16 patients by the absence of PRL response to thyrotropin-releasing factor (TRF) and a dopamine receptor antagonist, metoclopramide, without radiologic evidence of an adenoma." | 3.66 | Changes in pituitary hormones during and following transsphenoidal removal of prolactinomas. ( Alksne, J; Casper, RF; Gilliland, B; Quigley, ME; Rakoff, JS; Yen, SS, 1980) |
| "TRH, metoclopramide (MCP), chlorpromazine (CPZ), and insulin (ITT) stimulation tests of PRL secretion were carried out in age-matched controls and before and after successful removal of pituitary prolactinomas in women with the galactorrhea-amenorrhea syndrome." | 3.66 | Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome. ( Blackard, WG; Gardner, DF; Lankford, HV; Tucker, HS, 1980) |
| "The administration of a dopamine-receptor antagonist, metoclopramide (10 mg, intravenous bolus), elicited a significant increase in the circulating concentration of thyroid-stimulating hormone (TSH) which was substantially greater for hyperprolactinemic patients with pituitary microadenoma than for normal women during the early follicular phase of the cycle." | 3.66 | Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma. ( Quigley, ME; Yen, SS, 1980) |
| "The degree of autonomy in prolactin secreting pituitary adenomas and also prolactin secretory reserve in cases with suspected functional galactorrhea syndrome was evaluated with the use of metoclopramide, TRH and L-DOPA." | 3.66 | The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome. ( Jeske, W, 1979) |
| "Administration of a dopamine (DA) antagonist, metoclopramide (MCP) resulted in dose-related acute increments of circulating levels of LH and FSH in patients with hyperprolactinemic anovulation due to pituitary microadenoma but not in normal cycling women during the early follicular phase." | 3.66 | Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation. ( Gilliland, GB; Judd, SJ; Quigley, ME; Yen, SS, 1979) |
| "Differences between micro- and macroprolactinomas, as regards the prolactin secretory pattern in response to pharmacological challenges, have been reported in in vivo and in vitro models, and interpreted as being due to different dopaminergic regulation of prolactin release." | 2.68 | No difference between micro- and macroprolactinomas in the prolactin responsiveness to metoclopramide and dopamine administration. ( Braga, M; Cavagnini, F; Maraschini, C; Moro, M; Toja, P, 1996) |
| "Twelve patients suffering from macroprolactinoma were treated for at least 6 months with daily doses ranging from 50 up to 300 micrograms." | 1.29 | Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study. ( Althoff, P; Jungmann, E; Nickelsen, T; Schumm-Draeger, PM; Usadel, KH, 1993) |
| "Bromocriptine treatment (10 mg daily p." | 1.29 | Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment. ( Andonova, K; Andreeva, M; Kalinov, K; Matrozov, P; Stoeva, I; Zacharieva, S, 1996) |
| "A patient with a rare combination of prolactinoma and aldosterone producing adrenal adenoma (APA) was reported in relation to studies concerning dopaminergic regulation of PRL and aldosterone secretion." | 1.28 | A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion. ( Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M, 1992) |
| "The patients with microprolactinomas had a low prolactin response (increments less than 300-400%) and delayed TSH response." | 1.28 | [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women]. ( Balabolkin, MI; Gerasimov, GA; Liubimov, AV, 1990) |
| "Pretreatment with metoclopramide enhanced the CRH-induced cortisol increase from 30-120 min after CRH in normal men, but only at 15 and 30 min in 5 agromegalic patients." | 1.27 | Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion. ( Adachi, N; Endoh, M; Horino, M; Ishii, R; Kikuoka, M; Matsuki, M; Nishida, S; Otsuka, R; Oyama, H; Yoneda, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 60 (82.19) | 18.7374 |
| 1990's | 9 (12.33) | 18.2507 |
| 2000's | 1 (1.37) | 29.6817 |
| 2010's | 2 (2.74) | 24.3611 |
| 2020's | 1 (1.37) | 2.80 |
| Authors | Studies |
|---|---|
| Rodier, C | 1 |
| Courbière, B | 1 |
| Fernandes, S | 1 |
| Vermalle, M | 1 |
| Florence, B | 1 |
| Resseguier, N | 1 |
| Brue, T | 1 |
| Cuny, T | 1 |
| Wei, Y | 1 |
| La, L | 1 |
| Wang, L | 1 |
| Batey, R | 1 |
| Wang, C | 1 |
| Li, Y | 1 |
| Espinós, JJ | 1 |
| Vanrell, C | 1 |
| Gich, I | 1 |
| Urgell, E | 1 |
| Calaf, J | 1 |
| Nag', IuG | 1 |
| Clayton, RN | 1 |
| Bailey, LC | 1 |
| Teasdale, GM | 3 |
| Ratcliffe, JG | 3 |
| Thomson, JA | 4 |
| Cowden, EA | 4 |
| Rocco, A | 2 |
| Falaschi, P | 2 |
| Pompei, P | 1 |
| D'Urso, R | 2 |
| Frajese, G | 2 |
| Kasperlik-Zaluska, AA | 1 |
| Jeske, W | 2 |
| Nishida, S | 3 |
| Matsuki, M | 3 |
| Nagase, Y | 1 |
| Horino, M | 3 |
| Endoh, M | 3 |
| Kakita, K | 2 |
| Tenku, A | 2 |
| Oyama, H | 3 |
| Rowe, RC | 1 |
| Faiman, C | 1 |
| Friesen, HG | 1 |
| Spitz, IM | 1 |
| Haas, M | 1 |
| Trestian, S | 1 |
| Zylber-Haran, E | 1 |
| Shilo, S | 1 |
| Teasdale, G | 2 |
| Lu, YR | 1 |
| Balabolkin, MI | 2 |
| Gerasimov, GA | 2 |
| Seki, K | 3 |
| Uesato, T | 2 |
| Kato, K | 4 |
| Shima, K | 3 |
| Martin, RH | 1 |
| Witzgall, H | 1 |
| von Werder, K | 1 |
| Weber, PC | 1 |
| Pawlikowski, M | 1 |
| Komorowski, J | 1 |
| Owczarczyk, I | 1 |
| De Marinis, L | 7 |
| Mancini, A | 3 |
| Maira, G | 7 |
| Anile, C | 7 |
| Menini, E | 5 |
| Barbarino, A | 7 |
| Casper, RF | 1 |
| Rakoff, JS | 1 |
| Quigley, ME | 4 |
| Gilliland, B | 1 |
| Alksne, J | 1 |
| Yen, SS | 4 |
| Tucker, HS | 3 |
| Lankford, HV | 3 |
| Gardner, DF | 2 |
| Blackard, WG | 3 |
| Grubb, SR | 1 |
| Wigand, JP | 1 |
| Taylon, A | 1 |
| Becker, DP | 1 |
| De Giorgio, G | 1 |
| Toffano, G | 1 |
| Merlini, G | 1 |
| Jungmann, E | 3 |
| Böttger, B | 1 |
| Magnet, W | 1 |
| Schulz, F | 1 |
| Schwedes, U | 2 |
| Althoff, PH | 2 |
| Schöffling, K | 2 |
| De Gennes, JL | 1 |
| Turpin, G | 1 |
| Heshmati, HM | 1 |
| Carayon, A | 1 |
| Gasparoni, P | 1 |
| Fioretti, D | 1 |
| Roncato, F | 1 |
| Rota, G | 1 |
| Conte, N | 1 |
| Cooper, BT | 1 |
| Mountford, RA | 1 |
| McKee, C | 1 |
| Andersen, AN | 1 |
| Tabor, A | 1 |
| Judd, SJ | 3 |
| Gilliland, GB | 2 |
| Gonzalez-Villapando, C | 1 |
| Szabo, M | 1 |
| Frohman, LA | 1 |
| Verhelst, J | 1 |
| Beckers, A | 1 |
| Abs, R | 1 |
| Nickelsen, T | 1 |
| Althoff, P | 1 |
| Schumm-Draeger, PM | 1 |
| Usadel, KH | 1 |
| Maraschini, C | 1 |
| Moro, M | 1 |
| Toja, P | 1 |
| Braga, M | 1 |
| Cavagnini, F | 1 |
| Zacharieva, S | 1 |
| Stoeva, I | 1 |
| Andreeva, M | 1 |
| Kalinov, K | 1 |
| Matrozov, P | 1 |
| Andonova, K | 1 |
| Macpherson, P | 2 |
| Doyle, D | 2 |
| Pineda, G | 1 |
| Valdes, M | 1 |
| Castro, M | 1 |
| Stevenson, C | 1 |
| Bohnet, HG | 2 |
| Hanker, JP | 1 |
| Horowski, R | 1 |
| Wickings, EJ | 1 |
| Schneider, HP | 1 |
| Vázquez-Matute, L | 1 |
| Canales, ES | 1 |
| Alger, M | 1 |
| Zárate, A | 1 |
| Lazarus, L | 2 |
| Compton, P | 1 |
| Demura, R | 1 |
| Naruse, M | 1 |
| Isawa, M | 1 |
| Onoda, N | 1 |
| Naruse, K | 1 |
| Yamakado, M | 1 |
| Demura, H | 1 |
| Magner, JA | 1 |
| Kane, J | 1 |
| Gerasimov, G | 1 |
| Chernova, T | 1 |
| Goncharov, N | 1 |
| Klockenbusch, W | 1 |
| Distler, W | 1 |
| von Ditfurth, M | 1 |
| Graf, M | 1 |
| Jahn, K | 1 |
| Liubimov, AV | 1 |
| Chen, CF | 1 |
| Kurachi, H | 1 |
| Miyake, A | 2 |
| Aono, T | 1 |
| Tanizawa, O | 2 |
| Xia, P | 1 |
| Shi, YF | 1 |
| Ohmichi, M | 1 |
| Koike, K | 1 |
| Petraglia, F | 1 |
| De Leo, V | 1 |
| Nappi, C | 1 |
| Facchinetti, F | 1 |
| Montemagno, U | 1 |
| Brambilla, F | 1 |
| Genazzani, AR | 1 |
| Adachi, N | 1 |
| Yoneda, M | 1 |
| Kikuoka, M | 1 |
| Otsuka, R | 1 |
| Ishii, R | 1 |
| McLellan, AR | 1 |
| Connell, JM | 1 |
| Alexander, WD | 1 |
| Davies, DL | 1 |
| Serri, O | 2 |
| Beauregard, H | 1 |
| Somma, M | 1 |
| Comtois, R | 1 |
| Jilwan, N | 1 |
| Hardy, J | 1 |
| Aguirre Sánchez-Covisa, M | 1 |
| Ruiz-Valdepeñas, MP | 1 |
| Larrodera, L | 1 |
| Jaunsolo, MA | 1 |
| Hawkins, FG | 1 |
| Rosak, C | 1 |
| Gordon, D | 1 |
| Richards, A | 1 |
| Bulloch, R | 1 |
| Cohen, HN | 1 |
| Semple, CG | 1 |
| Beastall, GH | 1 |
| Ciocca, DR | 1 |
| Puy, LA | 1 |
| Stati, AO | 1 |
| Ho, KY | 1 |
| Smythe, GA | 1 |
| Compton, PJ | 1 |
| D'Amico, C | 1 |
| Passeri, M | 1 |
| Sambo, P | 1 |
| Wolf, AS | 1 |
| Vertosick, FT | 1 |
| Minnielli, S | 1 |
| Masala, R | 1 |
1 review available for metoclopramide and Pituitary Neoplasms
| Article | Year |
|---|---|
Surgical management of pituitary adenoma.
Topics: Acromegaly; Adenoma; Cushing Syndrome; Female; Humans; Metoclopramide; Pituitary Gland; Pituitary Ne | 1983 |
1 trial available for metoclopramide and Pituitary Neoplasms
| Article | Year |
|---|---|
No difference between micro- and macroprolactinomas in the prolactin responsiveness to metoclopramide and dopamine administration.
Topics: Adolescent; Adult; Dopamine; Female; Humans; Kinetics; Male; Metoclopramide; Middle Aged; Pituitary | 1996 |
71 other studies available for metoclopramide and Pituitary Neoplasms
| Article | Year |
|---|---|
Metoclopramide Test in Hyperprolactinemic Women With Polycystic Ovarian Syndrome: Old Wine Into New Bottles?
Topics: Female; Humans; Male; Metoclopramide; Pituitary Neoplasms; Polycystic Ovary Syndrome; Prolactinoma; | 2022 |
Paeoniflorin and liquiritin, two major constituents in Chinese herbal formulas used to treat hyperprolactinemia-associated disorders, inhibits prolactin secretion in prolactinoma cells by different mechanisms.
Topics: Animals; Cell Line, Tumor; Drugs, Chinese Herbal; Female; Flavanones; Glucosides; Hyperprolactinemia | 2017 |
Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
Topics: Adult; Dopamine D2 Receptor Antagonists; Female; Humans; Hyperprolactinemia; Metoclopramide; Middle | 2017 |
[Features of pituitary tumors and incidentalomas in hyper- and hypoprolactinemia].
Topics: Adult; Female; Humans; Hyperprolactinemia; Incidental Findings; Magnetic Resonance Imaging; Male; Me | 2008 |
Dopamine agonist- and antagonist-induced modulation of pituitary gonadotrophin releasing hormone receptors are independent of changes in serum prolactin.
Topics: Animals; Bromocriptine; Domperidone; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Ho | 1984 |
The prolactinoma problem.
Topics: Adenoma; Female; Hormones; Humans; Metoclopramide; Pituitary Function Tests; Pituitary Neoplasms; Pr | 1980 |
Reproductive parameters in prolactinaemic men.
Topics: Adenoma; Antipsychotic Agents; Bromocriptine; Erectile Dysfunction; Humans; Male; Metoclopramide; Pi | 1983 |
Serum prolactin responses to metoclopramide in Cushing's syndrome and Nelson's syndrome.
Topics: 17-Hydroxycorticosteroids; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Cushing Syndrome | 1980 |
Effect of changes in the plasma ACTH level on the prolactin response to metoclopramide or bromocriptine in normal subjects and patients with Nelson's syndrome.
Topics: Adrenocorticotropic Hormone; Bromocriptine; Dexamethasone; Humans; Metoclopramide; Nelson Syndrome; | 1984 |
Correlation of Nb2 bioassay and radioimmunoassay values for human serum prolactin.
Topics: Adult; Animals; Biological Assay; Cell Division; Cell Line; Domperidone; Female; Humans; Lymphoma; M | 1983 |
The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
Topics: Adult; Diagnosis, Differential; Dopamine Antagonists; Female; Follicle Stimulating Hormone; Gonadotr | 1983 |
[Clinical application of TRH and metoclopramide (MCP) stimulating tests for prolactin].
Topics: Adult; Amenorrhea; Female; Humans; Male; Metoclopramide; Middle Aged; Pituitary Gland, Anterior; Pit | 1983 |
[The use of radioimmunoassay in the diagnosis of various forms of endocrine infertility].
Topics: Adult; Female; Humans; Infertility, Female; Metoclopramide; Pituitary Neoplasms; Prolactin; Radioimm | 1984 |
Functional evaluation of the adenohypophysis with metoclopramide in hyperprolactinemic-amenorrheic women in relation to radiological findings on the sella turcica.
Topics: Adenoma; Adult; Amenorrhea; Female; Humans; Luteinizing Hormone; Metoclopramide; Pituitary Gland, An | 1984 |
Metoclopramide challenge: a measure of human lactotroph activity.
Topics: Adult; Breast Feeding; Diagnosis, Differential; Female; Humans; Lactation; Menopause; Menstruation; | 1983 |
Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism.
Topics: Adenoma; Adult; Female; Humans; Hyperaldosteronism; Kinetics; Male; Metoclopramide; Middle Aged; Min | 1983 |
[Serum prolactin level in basal conditions and after metoclopramide stimulation in women with galactorrhea and in patients with pituitary tumors].
Topics: Adult; Female; Galactorrhea; Humans; Lactation Disorders; Male; Metoclopramide; Pituitary Neoplasms; | 1983 |
Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide.
Topics: Adenoma; Adolescent; Adult; Dopamine; Female; Humans; Metoclopramide; Pituitary Function Tests; Pitu | 1984 |
Changes in pituitary hormones during and following transsphenoidal removal of prolactinomas.
Topics: Adenoma; Adult; Female; Follicle Stimulating Hormone; Follow-Up Studies; Growth Hormone; Humans; Lut | 1980 |
Normal pituitary function and reserve after selective transsphenoidal removal of a thyrotropin-producing pituitary adenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Levodopa; Metoclopramide; Microsurgery; Pituitary Gla | 1980 |
Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome.
Topics: Amenorrhea; Chlorpromazine; Female; Galactorrhea; Humans; Insulin; Lactation Disorders; Metocloprami | 1980 |
Galactorrhea-amenorrhea syndrome: follow-up of forty-five patients after pituitary tumor removal.
Topics: Adenoma; Adult; Amenorrhea; Chlorpromazine; Female; Follow-Up Studies; Galactorrhea; Humans; Lactati | 1981 |
Effects of thyrotropin-releasing hormone and metoclopramide in patients with phenothiazine-induced hyperprolactinemia.
Topics: Adult; Diagnosis, Differential; Female; Humans; Metoclopramide; Phenothiazines; Pituitary Neoplasms; | 1981 |
[Clinical and experimental studies of the mechanism of neuroendocrine action of cerebral phospholipids: the behavior of prolactin as a marker of such action].
Topics: Adenoma; Adult; Female; Humans; Liposomes; Male; Metoclopramide; Middle Aged; Phospholipids; Pituita | 1981 |
Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
Topics: Adenoma; Adolescent; Adult; Carbidopa; Dopamine; Female; Follow-Up Studies; Humans; Levodopa; Metocl | 1982 |
[Dopaminergic regulation of hormone secretion of the pituitary gland and the adrenal gland].
Topics: Acromegaly; Adrenal Glands; Adult; Aged; Dopamine; Female; Growth Hormone; Humans; Hydrocortisone; M | 1983 |
[Progress in the hormonal detection of pituitary prolactin adenoma].
Topics: Adenoma; Bromocriptine; Domperidone; Humans; Metoclopramide; Nomifensine; Pituitary Neoplasms; Prola | 1982 |
[Effect of bromopride on prolactin secretion].
Topics: Adenoma; Adolescent; Adult; Female; Humans; Male; Metoclopramide; Middle Aged; Pituitary Gland; Pitu | 1982 |
Central dopaminergic excitatory and inhibitory systems in Nelson's syndrome.
Topics: Adult; Brain; Female; Growth Hormone; Humans; Male; Metoclopramide; Middle Aged; Nelson Syndrome; Ne | 1982 |
Galactorrhoea, hyperprolactinaemia, and pituitary adenoma presenting during metoclopramide therapy.
Topics: Adenoma; Female; Galactorrhea; Humans; Lactation Disorders; Metoclopramide; Middle Aged; Pituitary N | 1982 |
Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
Topics: Adenoma; Adult; Breast Feeding; Female; Growth Hormone; Humans; Lactation; Luteinizing Hormone; Meto | 1982 |
Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma.
Topics: Adenoma; Adult; Dopamine; Female; Follicular Phase; Humans; Kinetics; Metoclopramide; Pituitary Neop | 1980 |
Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma.
Topics: Adenoma; Adult; Dopamine; Female; Humans; Hypothalamus; Menstruation; Metoclopramide; Pituitary Neop | 1980 |
Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Animals; Carbidopa; Cimetidine; Female; Guanidines; Humans; Levodopa; Ma | 1980 |
The effect of naloxone and metoclopramide on the secretion of luteinizing hormone in a hyperprolactinemic hypogonadotropic postmenopausal woman.
Topics: Aged; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Female; Follicle Stimulating Hormone; | 1995 |
Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study.
Topics: Adult; Aged; Aminoquinolines; Blood Pressure; Dopamine Agents; Female; Gonadal Steroid Hormones; Gon | 1993 |
Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
Topics: Adult; Aldosterone; Bromocriptine; Case-Control Studies; Dopamine Agonists; Dopamine Antagonists; Dr | 1996 |
Tests of prolactin secretion in diagnosis of prolactinomas.
Topics: Adolescent; Adult; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Metoclopramide; Parane | 1979 |
Biochemical diagnosis of pralactinoma.
Topics: Diagnostic Errors; Female; Hormones; Humans; Metoclopramide; Paraneoplastic Endocrine Syndromes; Pit | 1979 |
The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
Topics: Acromegaly; Adenoma; Adult; Amenorrhea; Female; Galactorrhea; Humans; Lactation Disorders; Levodopa; | 1979 |
Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Hypothalamus; Metergoline; Metoclopramide | 1979 |
Pituitary microadenoma: diagnostic studies.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Metoclopramide; Pituitary Function Tests; | 1979 |
Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
Topics: Adenoma; Adolescent; Adult; Female; Humans; Lactation; Metoclopramide; Pituitary Neoplasms; Pregnanc | 1978 |
Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disorders.
Topics: Adenoma; Administration, Oral; Adult; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Go | 1979 |
Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
Topics: Adenoma; Adult; Amenorrhea; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menst | 1979 |
Clinical use of metoclopramide test in the diagnosis of women with hyperprolactinemia.
Topics: Adult; Amenorrhea; Female; Galactorrhea; Humans; Male; Metoclopramide; Pituitary Neoplasms; Pregnanc | 1979 |
Hyperprolactinaemia: its physiology and investigation.
Topics: Adenoma, Chromophobe; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Male; Metabolic Disea | 1976 |
A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Bromocriptine; Dopamine; Female; Humans; Metoc | 1992 |
Binding of thyrotropin to lentil lectin is unchanged by thyrotropin-releasing hormone administration in three patients with thyrotropin-producing pituitary adenomas.
Topics: Adenoma; Adult; Chromatography, Affinity; Female; Humans; Hyperthyroidism; Immunoradiometric Assay; | 1992 |
Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
Topics: Adenoma; Adult; Cyproheptadine; Dopamine; Female; Humans; Hyperprolactinemia; Hypothyroidism; Metocl | 1992 |
[The value of functional tests in diagnosis of prolactinoma].
Topics: Circadian Rhythm; Female; Humans; Hyperprolactinemia; Metoclopramide; Pituitary Neoplasms; Prolactin | 1990 |
[Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women].
Topics: Adult; Diagnosis, Differential; Female; Humans; Hyperprolactinemia; Hypogonadism; Metoclopramide; Pi | 1990 |
Suppression of serum immunoreactive human epidermal growth factor by acute increase in prolactin in women.
Topics: Adenoma; Adolescent; Adult; Epidermal Growth Factor; Female; Humans; Hyperprolactinemia; Metoclopram | 1989 |
Evaluation of hypothalamic dopaminergic function in patients with pituitary prolactinoma.
Topics: Adult; Carbidopa; Female; Humans; Levodopa; Luteinizing Hormone; Metoclopramide; Pituitary Neoplasms | 1989 |
A simple rapid method for prolactin assay by reversed passive hemagglutination: evaluation of its clinical application.
Topics: Amenorrhea; Antibodies, Monoclonal; Bromocriptine; Female; Hemagglutination Tests; Humans; Metoclopr | 1989 |
Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
Topics: Adenoma; Adult; Amenorrhea; Antipsychotic Agents; Dopamine Antagonists; Endorphins; Female; Humans; | 1987 |
Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion.
Topics: Acromegaly; Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Aged; Catecholamines; Corticotropin- | 1987 |
Clinical response of thyrotropin-secreting macroadenoma to bromocriptine and radiotherapy.
Topics: Adenoma; Bromocriptine; Dexamethasone; Humans; Iodine Radioisotopes; Male; Metoclopramide; Middle Ag | 1988 |
Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
Topics: Adenoma; Adult; Dopamine; Female; Humans; Hyperprolactinemia; Metoclopramide; Middle Aged; Pituitary | 1988 |
Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia.
Topics: Adult; Aldosterone; Female; Humans; Hyperprolactinemia; Metoclopramide; Middle Aged; Pituitary Neopl | 1987 |
[The metoclopramide and nomifensine tests in the diagnosis of prolactinomas].
Topics: Diagnosis, Differential; Female; Humans; Hyperprolactinemia; Male; Metoclopramide; Nomifensine; Pitu | 1986 |
Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
Topics: Adenoma; Adult; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Luteinizing Hormone; Metoc | 1986 |
Evidence for increased endogenous dopaminergic inhibition of aldosterone secretion in prolactinoma.
Topics: Adult; Aldosterone; Dopamine; Female; Humans; Male; Metoclopramide; Middle Aged; Pituitary Neoplasms | 1986 |
Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
Topics: Female; Humans; Menstruation; Metoclopramide; Pituitary Function Tests; Pituitary Neoplasms; Postope | 1985 |
Immunocytochemical evidence for the ability of the human pharyngeal hypophysis to respond to change in endocrine feedback.
Topics: Adenoma; Adolescent; Aged; Bronchial Diseases; Endocrine Glands; Feedback; Female; Histocytochemistr | 1985 |
Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Male; Metoclopramide; Middle Aged; Pituit | 1985 |
Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
Topics: Adenoma; Adenoma, Chromophobe; Adolescent; Adult; Craniopharyngioma; Female; Follicle Stimulating Ho | 1985 |
Treatment of hyperprolactinemic amenorrhea with Metergoline.
Topics: Adenoma; Adult; Amenorrhea; Ergolines; Female; Humans; Hyperprolactinemia; Metergoline; Metocloprami | 1986 |
Role of defective dopaminergic inhibition of prolactin secretion in the pathogenesis of prolactinoma.
Topics: Autoantibodies; Carbidopa; Dopamine; Female; Humans; Hypothalamo-Hypophyseal System; Levodopa; Metoc | 1985 |
Twenty-four hour secretory pattern of thyroid-stimulating hormone in hyperprolactinemic women with pituitary microadenoma.
Topics: Adenoma; Adult; Circadian Rhythm; Female; Humans; Hyperprolactinemia; Metoclopramide; Pituitary Glan | 1985 |
Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
Topics: Adenoma; Adolescent; Adult; Diagnosis, Differential; Empty Sella Syndrome; Female; Humans; Hyperprol | 1985 |